ÂÜÀòÂÒÂ×

Audrey Mulder is an experienced professional in pharmaceutical and biopharmaceutical sectors, currently serving as Head of Ophthalmics and Rare Disease in Global Operational Excellence at Astellas Pharma since May 2024. Previously held the position of Director of Medical Affairs Portfolio Project Management at Astellas Europe from May 2021 to May 2024. Audrey's career includes roles at GSK as Director of Medical Project Management, Astellas Pharma Europe as Global Medical Affairs Program Management, and various contractor positions at ProductLife Group and Prescient Healthcare Group. Notable contributions include leadership in project management and competitive intelligence at companies like Daiichi Sankyo and Antisoma. Audrey holds a Master of Science in Biotechnology from UNSW, a Bachelor of Science with honors in Applied Biology from Kingston University, and a DUT in Pharmacology from Université de Rouen.